[go: up one dir, main page]

Schmid et al., 1997 - Google Patents

Adenovirus mediated gene transfer into rat lung grafts at the time of harvest

Schmid et al., 1997

View PDF
Document ID
12861745933009372791
Author
Schmid R
Narita M
Boasquevisque C
Ando K
Botney M
Cooper J
Schwartz A
Patterson G
Publication year
Publication venue
European journal of cardio-thoracic surgery

External Links

Snippet

OBJECTIVE: New methods to introduce genetic material into cells in vivomay revolutionize current treatment modalities. Expression of functionalgenes in lung allografts could be used as a prophylactic strategy forreperfusion injury and rejection. We studied the feasibility of ex …
Continue reading at academic.oup.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors

Similar Documents

Publication Publication Date Title
Lemarchand et al. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors.
DE69333886T2 (en) Adenovirus-guided gene transfer to the heart and smooth vascular muscle
Mastrangeli et al. Direct in vivo adenovirus-mediated gene transfer to salivary glands
US20110044947A1 (en) Methods of treating cardiac disorders
Abunasra et al. Efficacy of adenoviral gene transfer with manganese superoxide dismutase and endothelial nitric oxide synthase in reducing ischemia and reperfusion injury
US6689090B1 (en) Perfusion apparatus and methods for pharmaceutical delivery
Christensen et al. High-efficiency, long-term cardiac expression of foreign genes in living mouse embryos and neonates
Merrick et al. COMPARISON OF ADENOVIRUS GENE TRANSFER TO VASCULAR ENDOTHELIAL CELLS IN CELL CULTURE, ORGAN CULTURE, AND IN VIVO1
De Roos et al. Isolated-organ perfusion for local gene delivery: efficient adenovirus-mediated gene transfer into the liver
Kypson et al. Ex vivo adenovirus-mediated gene transfer to the adult rat heart
Schneider et al. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B
Türkay et al. Intrauterine gene transfer: gestational stage-specific gene delivery in mice
US6342214B1 (en) Method for viral vector delivery
Chapelier et al. Gene therapy in lung transplantation: feasibility of ex vivo adenovirus-mediated gene transfer to the graft
Gao et al. Gene delivery followed by ex vivo lung perfusion using an adeno-associated viral vector in a rodent lung transplant model
Matsui Endothelial progenitor cell-based therapy for hemophilia A
Connelly et al. Gene therapy for hemophilia A
Schmid et al. Adenovirus mediated gene transfer into rat lung grafts at the time of harvest
Barbu et al. A perfusion protocol for highly efficient transduction of intact pancreatic islets of Langerhans
Boasquevisque et al. Ex vivo adenoviral-mediated gene transfer to lung isografts during cold preservation
Rentsch et al. Adenoviral bcl-2 transfer improves survival and early graft function after ischemia and reperfusion in rat liver transplantation
US20020062121A1 (en) Perfusion apparatus and methods for pharmaceutical delivery
Pellegrini et al. Highly efficient ex vivo gene transfer to the transplanted heart by means of hypothermic perfusion with a low dose of adenoviral vector
Roks et al. Vectors based on Semliki Forest virus for rapid and efficient gene transfer into non-endothelial cardiovascular cells: comparison to adenovirus
Byun et al. Myocardial injury‐induced fibroblast proliferation facilitates retroviral‐mediated gene transfer to the rat heart in vivo